Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • izy
    Junior Member
    • Mar 2024
    • 1

    #1

    Multifactor Integration into single seuratobject or multiple seuratobjects? (single cell RNAseq)

    Hello,

    I am doing single cell RNA-seq analysis. I have 2 groups of samples: Test and WT. For both groups, I have 2 different data: treated and untreated. My samples are a composition of various cell types, but each of my samples have the same variety of cell types (The samples are taken from the same tissue, so each sample has same composition. But they consist of various cell types, it is not cell-line.)

    I want to compare:
    untreated WT vs treated WT
    untreated WT vs untreated Test
    untreated Test vs treated Test
    treated WT vs treated Test​

    My question is, is it a good idea to do the analysis of the data in the same seuratobject? For example, by using multifactor integration into a single seuratobject? Or should I make separate seuratobjects for the variables?

    I am worried that the clustering and DEGs will get affected if I include everything into a single seuratobject. (I want the clustering to be by cell types) But the DEGs will probably be different before/after treatment.

    Thank you

Latest Articles

Collapse

  • SEQadmin2
    Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
    by SEQadmin2



    CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

    Despite this, “CRISPR helped turn genome editing from a specialized technique into
    ...
    07-31-2026, 11:01 AM
  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 10:35 AM
0 responses
7 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-06-2026, 07:41 AM
0 responses
25 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 08-03-2026, 10:13 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-31-2026, 02:55 AM
0 responses
48 views
0 reactions
Last Post SEQadmin2  
Working...